JAX Tech Talk Episode 59: Let’s Talk iPSCs and Their Value in Tackling Neurodegenerative Diseases (Sep. 20, 2022)

Dr. Mark Cookson talks about the unique aspects of the collection of human isogenic iPSC lines and how it can benefit the wider scientific community in their shared quest to understand and fight ADRD.

In Vivo Drug Discovery Platforms for Amyotrophic Lateral Sclerosis

Watch this webinar to review phenotypic characteristics, considerations for selecting therapeutically relevant ALS models, and more!

JAX Tech Talk Episode 41: Let’s Talk Cre-Lox for Neuroscientists (Aug. 10, 2021)

Aug. 10, 2021 - In this episode, we will explore the use of Cre-lox technology to control gene expression in neuronal cell types, and more.

MODEL-AD: Creating new mouse models for late-onset Alzheimer’s disease

Early Electrophysiology & Biochemical Biomarkers in Mouse Models for Amyotrophic Lateral Sclerosis.

Mouse Models of Rett Syndrome

The establishment ​of a new platform to assess preclinical allele ​dependent phenotypes​

Overview of Friedreich’s Ataxia Models - Cat Lutz, Ph.D.

MiceTech Talk Episode 22: Let’s Talk Exploring Neurobiology Solutions (Oct. 27, 2020)

October 27, 2020 - In this episode, we share with you highlights of JAX preclinical research studies using mouse models for ALS, Rett Syndrome, Friedreich's Ataxia, and more!

A View on ALS Drug Discovery - Learnings From the Front Lines of Translational Disease Modeling

Join Cat Lutz, Ph.D., Senior Director In Vivo Pharmacology & Mouse Repository at JAX as she'll discuss neurodegenerative diseases, rare diseases, and her group’s latest work in preclinical studies usi

MiceTech Talk Episode 12: Let's Talk Latest Advances in Alzheimer's Disease Research (Aug. 4, 2020)

August 4, 2020 - We highlight some of the latest studies and discoveries presented at the AAIC Conference, the most influential international meeting dedicated to advancing dementia science.